Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Cullinan Oncology (CGEM)

Annual Return

Over the past 3 years, CGEM has had an average annual return of +19.96%, outperforming the benchmark SPY, which returned +19.62% annual.

Over the past 5 years, CGEM has had an average annual return of -7.13%, underperforming the benchmark SPY, which returned +12.73% annual.

Since Jan 8, 2021, CGEM has had an average annual return of -8.71%, underperforming the benchmark SPY, which returned +14.49% annual.

202620252024202320222021
+74.51%-15.03%+19.52%-3.40%-31.63%-48.41%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+15.58%+29.58%-8.32%-8.17%+25.97%+10.77%-0.82%+74.51%
2025-13.29%-19.60%-10.85%+9.36%+4.41%-12.87%+3.18%-2.96%-21.34%+45.99%+31.30%-8.97%-15.03%
2024+48.58%+21.99%-7.74%+58.50%-12.99%-25.79%+10.94%+1.30%-14.59%-7.11%-13.50%-9.45%+19.52%
2023+10.35%-3.01%-9.40%-4.88%+5.66%+4.66%-1.56%-2.29%-12.54%+3.07%-12.22%+24.43%-3.40%
2022-12.64%+6.37%-26.97%-6.31%+8.96%+19.92%+5.39%-0.22%-4.90%+2.50%-5.39%-15.13%-31.63%
2021+27.08%+6.34%+3.09%-22.10%-8.41%-13.39%-10.95%+23.08%-20.02%-1.55%-18.99%-14.27%-48.41%

Drawdown analysis of Cullinan Oncology (CGEM)

The maximum drawdown for the CGEM was -89.24%, occurring on Oct 2, 2025. This drawdown has not yet recovered.

The current CGEM drawdown is -66.19%.

Since Jan 8, 2021 CGEM has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 4 times
DepthStartTo BottomBottomTo RecoverEndTotal
-89.24%Mar 10, 20211147Oct 2, 2025OngoingOngoingOngoing
-17.29%Mar 2, 20212Mar 4, 20214Mar 10, 20216
-12.59%Jan 25, 20217Feb 3, 20216Feb 11, 202113
-11.61%Feb 19, 20215Feb 26, 20211Mar 1, 20216
-9.66%Jan 14, 20212Jan 19, 20211Jan 20, 20213
-6.39%Jan 8, 20211Jan 11, 20212Jan 13, 20213
-0.23%Feb 17, 20211Feb 18, 20211Feb 19, 20212